AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT
Authors: NOGA SJ SEBER A DAVIS JM BERENSON RJ VOGELSANG GB BRAINE HG HESS AD MARCELLUS D MILLER CA SHARKIS SJ GOODMAN SN SANTOS GW JONES RJ
Citation: Sj. Noga et al., CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT, Journal of hematotherapy, 7(2), 1998, pp. 151-157
EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM)
Authors: SOMLO G SNIECINSKI I ODOMMARYON T NOWICKI B CHOW W HAMASAKI V LEONG L MARGOLIN K MORGAN R RASCHKO J SHIBATA S TETEF M MOLINA A BERENSON RJ FORMAN SJ DOROSHOW JH
Citation: G. Somlo et al., EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM), Blood, 89(5), 1997, pp. 1521-1528
TRANSPLANTATION OF CD34+ HEMATOPOIETIC PROGENITOR CELLS
Authors: BERENSON RJ SHPALL EJ AUDITOREHARGREAVES K HEIMFELD S JACOBS C KRIEGER MS
Citation: Rj. Berenson et al., TRANSPLANTATION OF CD34+ HEMATOPOIETIC PROGENITOR CELLS, Cancer investigation, 14(6), 1996, pp. 589-596
ENRICHMENT OF CD34-CELL PRODUCTS OBTAINED FROM HAPLOIDENTICAL NORMAL DONORS BY APHERESIS OF G-CSF MOBILIZED PERIPHERAL-BLOOD CELLS AND COLLECTION OF BONE-MARROW( CELLS AND DEPLETION OF CD3+ CELLS FROM HEMATOPOIETIC STEM)
Authors: HOLLAND HK YEAGER AM GELLER RB WINGARD JR MCCOLLUM J FORTE KJ MOGUL MJ JACOBS CA BERENSON RJ
Citation: Hk. Holland et al., ENRICHMENT OF CD34-CELL PRODUCTS OBTAINED FROM HAPLOIDENTICAL NORMAL DONORS BY APHERESIS OF G-CSF MOBILIZED PERIPHERAL-BLOOD CELLS AND COLLECTION OF BONE-MARROW( CELLS AND DEPLETION OF CD3+ CELLS FROM HEMATOPOIETIC STEM), Experimental hematology, 23(8), 1995, pp. 759-759
DEVELOPMENT AND VALIDATION OF A CYTOKINE-BASED ASSAY FOR THE MEASUREMENT OF HUMAN LTC-IC
Authors: HEIMFELD S FEI R XU J FOGARTY B BECKMANN MP JONES HM BERENSON RJ
Citation: S. Heimfeld et al., DEVELOPMENT AND VALIDATION OF A CYTOKINE-BASED ASSAY FOR THE MEASUREMENT OF HUMAN LTC-IC, Experimental hematology, 23(8), 1995, pp. 818-818
OPTIMIZATION AND CHARACTERIZATION OF THE IMMUNOAFFINITY SELECTION OF CD34(+) CELLS FOR CLINICAL USE
Authors: ARSENIEV L BATTMER K KADAR JG BERENSON RJ SUDMEIER I BONE LH
Citation: L. Arseniev et al., OPTIMIZATION AND CHARACTERIZATION OF THE IMMUNOAFFINITY SELECTION OF CD34(+) CELLS FOR CLINICAL USE, Experimental hematology, 23(8), 1995, pp. 853-853
TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD AND BONE-MARROW CD34(+) CELLS AFTER IMMUNOSELECTION
Authors: ARSENIEV LH BAHRE O KADAR JG BERENSON RJ BATTMER K KUHL J JACOBS R SCHUBERT J CASPER J DIEDRICH H
Citation: Lh. Arseniev et al., TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD AND BONE-MARROW CD34(+) CELLS AFTER IMMUNOSELECTION, Experimental hematology, 23(8), 1995, pp. 855-855
RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO
Authors: BRUGGER W HEIMFELD S BERENSON RJ MERTELSANN R KANZ L
Citation: W. Brugger et al., RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO, The New England journal of medicine, 333(5), 1995, pp. 283-287
ACCESSORY CELLS DO NOT CONTRIBUTE TO G-CSF OR IL-6 PRODUCTION NOR TO RAPID HEMATOLOGICAL RECOVERY FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: WATTS MJ JONES HM SULLIVAN AM LANGABEER SE JAMIESON E FIELDING A WILLIAMS C BERENSON RJ GOLDSTONE AH LINCH DC
Citation: Mj. Watts et al., ACCESSORY CELLS DO NOT CONTRIBUTE TO G-CSF OR IL-6 PRODUCTION NOR TO RAPID HEMATOLOGICAL RECOVERY FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, British Journal of Haematology, 91(3), 1995, pp. 767-772
COMBINED TRANSPLANTATION OF ALLOGENEIC BONE-MARROW AND CD34(-CELLS() BLOOD)
Authors: LINK H ARSENIEV L BAHRE O BERENSON RJ BATTMER K KADAR JG JACOBS R CASPER J KUHL J SCHUBERT J DIEDRICH H POLIWODA H
Citation: H. Link et al., COMBINED TRANSPLANTATION OF ALLOGENEIC BONE-MARROW AND CD34(-CELLS() BLOOD), Blood, 86(7), 1995, pp. 2500-2508
USE OF CD34 POSITIVE AUTOLOGOUS HEMATOPOIETIC PROGENITORS TO SUPPORT PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY
Authors: CAGNONI PJ JONES RB FRANKLIN W HAMI L BERENSON RJ JACOBS C ROSS M BEARMAN SI SHPALL EJ
Citation: Pj. Cagnoni et al., USE OF CD34 POSITIVE AUTOLOGOUS HEMATOPOIETIC PROGENITORS TO SUPPORT PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1533-1533
PREPARATION AND SUCCESSFUL ENGRAFTMENT OF PURIFIED CD34(-MARROW PROGENITOR CELLS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA() BONE)
Authors: GORIN NC LOPEZ M LAPORTE JP QUITTET P LESAGE S LEMOINE F BERENSON RJ ISNARD F GRANDE M STACHOWIAK J LABOPIN M FOUILLARD L MOREL P JOUET JP NOELWALTER MP DETOURMIGNIES L AOUDJHANE M BAUTERS F NAJMAN A DOUAY L
Citation: Nc. Gorin et al., PREPARATION AND SUCCESSFUL ENGRAFTMENT OF PURIFIED CD34(-MARROW PROGENITOR CELLS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA() BONE), Blood, 85(6), 1995, pp. 1647-1654
SELECTION AND TRANSPLANTATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS
Authors: AUDITOREHARGREAVES K HEIMFELD S BERENSON RJ
Citation: K. Auditorehargreaves et al., SELECTION AND TRANSPLANTATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS, Bioconjugate chemistry, 5(4), 1994, pp. 287-300
TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT
Authors: SHPALL EJ JONES RB BEARMAN SI FRANKLIN WA ARCHER PG CURIEL T BITTER M CLAMAN HN STEMMER SM PURDY M MYERS SE HAMI L TAFFS S HEIMFELD S HALLAGAN J BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT, Journal of clinical oncology, 12(1), 1994, pp. 28-36
EX-VIVO EXPANSION OF HUMAN MARROW AND CORD-BLOOD CD34(+) PROGENITOR CELLS
Authors: HEIMFELD S FEI R TSUI J THOMPSON P BERENSON RJ
Citation: S. Heimfeld et al., EX-VIVO EXPANSION OF HUMAN MARROW AND CORD-BLOOD CD34(+) PROGENITOR CELLS, Journal of cellular biochemistry, 1994, pp. 11-11
ISOLATION AND EX-VIVO EXPANSION OF CD34(-BLOOD USING DEXTRAN SEDIMENTATION AND AVIDIN COLUMN SELECTION() CELLS FROM CORD)
Authors: HEIMFELD S KALAMASZ DF FOGARTY BL FEI R TSUI ZN JONES HM BERENSON RJ
Citation: S. Heimfeld et al., ISOLATION AND EX-VIVO EXPANSION OF CD34(-BLOOD USING DEXTRAN SEDIMENTATION AND AVIDIN COLUMN SELECTION() CELLS FROM CORD), Blood cells, 20(2-3), 1994, pp. 397-403
AUGMENTING ELUTRIATED MARROW WITH CD34-CELLS IMPROVES ENGRAFTMENT KINETICS AND DECREASES HOSPITALIZATION AND MORBIDITY ASSOCIATED WITH T-CELL DEPLETION( SMALL STEM)
Authors: NOGA SJ DAVIS JM BERENSON RJ JONES RJ
Citation: Sj. Noga et al., AUGMENTING ELUTRIATED MARROW WITH CD34-CELLS IMPROVES ENGRAFTMENT KINETICS AND DECREASES HOSPITALIZATION AND MORBIDITY ASSOCIATED WITH T-CELL DEPLETION( SMALL STEM), Experimental hematology, 22(8), 1994, pp. 696-696
EX-VIVO EXPANSION OF HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS
Authors: FEL R HEIMFELD S XU Z FOGARTY B JONES HM THOMPSON P BERENSON RJ
Citation: R. Fel et al., EX-VIVO EXPANSION OF HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 22(8), 1994, pp. 726-726
EX-VIVO EXPANSION ANALYSIS FROM CD34(-DR(+(), HLA)-), CD33(+/-), AND CD38(+/-) SUBSETS/
Authors: HEIMFELD S FOGARTY B FEI R XU Z THOMPSON P JONES HM BERENSON RJ PAPAYANNOPOLOU T
Citation: S. Heimfeld et al., EX-VIVO EXPANSION ANALYSIS FROM CD34(-DR(+(), HLA)-), CD33(+/-), AND CD38(+/-) SUBSETS/, Experimental hematology, 22(8), 1994, pp. 756-756
TRANSPLANTATION OF CD34+ MARROW AND OR PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) INTO PATIENTS WITH BREAST-CANCER OR NON-HODGKINS-LYMPHOMA FOLLOWING HIGH LOSE CHEMOTHERAPY/
Authors: SHPALL EJ JONES RB PURDY MH FRANKLIN WA HEIMFELD S BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF CD34+ MARROW AND OR PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) INTO PATIENTS WITH BREAST-CANCER OR NON-HODGKINS-LYMPHOMA FOLLOWING HIGH LOSE CHEMOTHERAPY/, Experimental hematology, 22(8), 1994, pp. 774-774
POSITIVELY SELECTED AUTOLOGOUS BLOOD CD34-BLOOD PROGENITOR CELLS MEDIATE IDENTICAL HEMATOPOIETIC ENGRAFTMENT AFTER HIGH-DOSE VP16, IFOSFAMIDE, CARBOPLATIN, AND EPIRUBICIN( CELLS AND UNSEPARATED PERIPHERAL)
Authors: BRUGGER W HENSCHLER R HEIMFELD S BERENSON RJ MERTELSMANN R KANZ L
Citation: W. Brugger et al., POSITIVELY SELECTED AUTOLOGOUS BLOOD CD34-BLOOD PROGENITOR CELLS MEDIATE IDENTICAL HEMATOPOIETIC ENGRAFTMENT AFTER HIGH-DOSE VP16, IFOSFAMIDE, CARBOPLATIN, AND EPIRUBICIN( CELLS AND UNSEPARATED PERIPHERAL), Blood, 84(5), 1994, pp. 1421-1426
GRAFT ENGINEERING .3. CD34+ AUGMENTATION ELUTRIATION (A E) ALLOWS REDUCTION IN GVHD PROPHYLAXIS WITHOUT AFFECTING ENGRAFTMENT/
Authors: NOGA SJ DAVIS JM BERENSON RJ VOGELSANG GB HESS AD JONES RJ
Citation: Sj. Noga et al., GRAFT ENGINEERING .3. CD34+ AUGMENTATION ELUTRIATION (A E) ALLOWS REDUCTION IN GVHD PROPHYLAXIS WITHOUT AFFECTING ENGRAFTMENT/, Blood, 84(10), 1994, pp. 10000089-10000089
CD34-BLOOD PROGENITOR CELLS (PBPCS) TO SUPPORT THE DELIVERY OF MULTIPLE CYCLES OF DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN (CD) WITHG-CSF PLUS ERYTHROPOIETIN (EPO) IN CHEMOTHERAPY-NAIVE BREAST-CANCER PATIENTS( SELECTED PERIPHERAL)
Authors: DEMETRI GD BERENSON RJ CAP B BLUMSACK R SHAPIRO T AUSTIN E SUGRUE M HAYES DF
Citation: Gd. Demetri et al., CD34-BLOOD PROGENITOR CELLS (PBPCS) TO SUPPORT THE DELIVERY OF MULTIPLE CYCLES OF DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN (CD) WITHG-CSF PLUS ERYTHROPOIETIN (EPO) IN CHEMOTHERAPY-NAIVE BREAST-CANCER PATIENTS( SELECTED PERIPHERAL), Blood, 84(10), 1994, pp. 10000207-10000207
DEVELOPMENT OF A CYTOKINE-BASED (NON-STROMAL CELL-DEPENDENT) ASSAY FOR THE MEASUREMENT OF HUMAN LTC-IC
Authors: HEIMFELD S FEI R XU J FOGARTY B JONES HM BERENSON RJ
Citation: S. Heimfeld et al., DEVELOPMENT OF A CYTOKINE-BASED (NON-STROMAL CELL-DEPENDENT) ASSAY FOR THE MEASUREMENT OF HUMAN LTC-IC, Blood, 84(10), 1994, pp. 10000275-10000275
EX-VIVO EXPANDED PERIPHERAL-BLOOD CD34-PATIENTS AFTER HIGH-DOSE VP16,IFOSFAMIDE, CARBOPLATIN AND EPIRUBICIN( CELLS MEDIATE HEMATOPOIETIC RECOVERY IN CANCER)
Authors: BRUGGER W SCHEDING S HEIMFELD S BERENSON RJ FARBER L MERTELSMANN R KANZ L
Citation: W. Brugger et al., EX-VIVO EXPANDED PERIPHERAL-BLOOD CD34-PATIENTS AFTER HIGH-DOSE VP16,IFOSFAMIDE, CARBOPLATIN AND EPIRUBICIN( CELLS MEDIATE HEMATOPOIETIC RECOVERY IN CANCER), Blood, 84(10), 1994, pp. 10000395-10000395
Risultati: 1-25 | 26-41